Exceptional Ventures
VC Fund
London, United Kingdom
Exceptional Ventures is an early-stage venture capital firm that invests in entrepreneurs and businesses that improve people's lives. Founded in 2022 and is based in London, England.
- Total investments:
- 38
- Last investment:
- Lead investor:
- 8%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Exceptional Ventures invests in
Stages Exceptional Ventures invests in
Countries Exceptional Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Seed
- $1.6M–$5.3M
- Pre-Seed
- $641k–$6.9M
- Convertible Note
- $1.3M–$3.7M
Investment Focus
Industry
- Health Care 11 (29%)
- Biotechnology 7 (18%)
- Wellness 5 (13%)
- Personal Health 4 (11%)
- Food Processing 3 (8%)
Stage
- Seed 15 (39%)
- Pre-Seed 9 (24%)
- Convertible Note 6 (16%)
- Series A 3 (8%)
- Angel 1 (3%)
Country
- United Kingdom 15 (39%)
- Italy 3 (8%)
- United States 3 (8%)
- France 1 (3%)
- Belgium 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Matt Cooper
Co-Founder and Executive Chairman
|
Co-Founder and Executive Chairman | Total investments: 1 | Find email | |
|
Paolo Pio
Co-Founder and General Partner
|
Co-Founder and General Partner | Total investments: 5 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Amatera is a biotechnology research company that leverages the latest techniques in biotechnology, to create coffee varieties. Amatera urges to make coffee varieties more sustainable and climate resistant to fill that massive demand. Founded by Omar Dekkiche and Lucie Kriegshauser in 2022 and is located in Paris, France. | $7M / Seed / Mar 04, 2026 | |
|
|
Evaro provides digital health integration to increase accessibility of pharmacy products. | $25M / Series A / Jan 26, 2026 | |
|
|
Gladys is a revolutionary social care software platform set to transform the caregiving landscape through innovation, empowerment, and direct connections. With a commitment to cutting out intermediaries, Gladys brings local carers, helpers, and families together in a seamless digital ecosystem. Led by a seasoned co-founding team with extensiveexperience in the sector, Gladys is uniquely positioned to address the challenges faced by the social care industry. As a female-led tech business based in the UK, Gladys is dedicated to driving change, simplifying processes, and enhancing the quality of care provided to vulnerable individuals. Backed by venture capital firm Antler, Gladys is poised to redefine social care, empowering caregivers and families. | $2M / Seed / Oct 13, 2025 | |
|
|
Unfabled is a women’s health consumer platform that delivers curated and personalised solutions. | $1.7M / Seed / Oct 13, 2025 | |
|
|
Open Health Technologies provides FHIR-based lab and medical data integration with API delivery, form design, orchestration, and dashboards. | $3M / Seed / Sep 11, 2025 | |
|
|
All the health information we need is within us. Just below the skin. SAVA is redefining the way people interact with their health by developing the most advanced biosensing technology science has to offer, capable of accessing bodily information in a painless, real-time and affordable way. | $18.8M / Series A / Jul 30, 2025 | |
|
|
Alba Health is a wellness product. It is not intended to diagnose or treat disease, and it is not a substitute for medical advice. | $2.5M / Seed / May 27, 2025 | |
|
|
ReportAId is a artificial intelligence company that provides health data for medical reports that is used by patients, doctors, hospitals. | $2.5M / Pre-Seed / May 06, 2025 | |
|
|
Level Zero Health focuses on advanced biosensor technology to collect new types of data by combining biochemistry and nanotechnology. | $6.9M / Pre-Seed / Feb 18, 2025 | |
|
|
Jove is an insurtech company to provide flexible bundled insurance for contractors and freelancers | $4.5M / Seed / Nov 29, 2024 | |
| See all 38 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Exceptional Ventures invest in?
Exceptional Ventures invests primarily in Health Care, Biotechnology and Wellness startups, most often at Seed and Pre-Seed stage. Most of the 38 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Exceptional Ventures's check size?
Exceptional Ventures typically joins rounds of $1.6M–$5.3M at Seed, $641k–$6.9M at Pre-Seed and $1.3M–$3.7M at Convertible Note. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Exceptional Ventures participates in.
How do I contact Exceptional Ventures?
Public channels for Exceptional Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Exceptional Ventures?
The team at Exceptional Ventures includes Matt Cooper (Co-Founder and Executive Chairman) and Paolo Pio (Co-Founder and General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!